Ischemic Stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients must meet the diagnostic criteria of both Western medicine and Traditional Chinese Medicine, with a disease course of more than 2 weeks but less than 6 months, and be in the recovery phase; (2) All patients must have no history of ischemic or hemorrhagic stroke prior to this incident, and this must be their first occurrence; (3) Patients must be aged between 40 and 75 years old; (4) The infarct lesion must be located in the unilateral motor pathway (unilateral basal ganglia and/or corona radiata); (5) Blood pressure must be stable below 160/100 mmHg; (6) Motor dysfunction must be related to ischemic stroke, and there must be no prior motor dysfunction caused by other diseases before the stroke; (7) Unilateral limb motor dysfunction must be present (simplified FMA score <99 points); (8) Vital signs must be stable, with no language or hearing impairments, and patients must be able to cooperate with treatment; (9) Patients must be willing to accept the treatment plan of this study, voluntarily participate in the research, and sign the informed consent form; (10) All patients must be determined to be right-handed according to the Edinburgh Handedness Inventory; (11) Patients must have a relatively stable condition and be able to cooperate with MRI scans and clinical data collection; (12) Patients must not have taken psychotropic drugs in the past month; (13) Patients must have no contraindications for MRI examinations. All patients must meet the above 13 criteria.
Exclusion criteria
Exclusion criteria: (1) Those with a history of hemorrhagic stroke and ischemic stroke; (2) Those with severe primary diseases such as heart, lung, liver, gallbladder, kidney, pancreas, hematopoietic system diseases, and malignant tumors; (3) Those with poor compliance or severe aphasia, severe hearing impairment, intellectual disability, or comprehension that make it impossible to cooperate with the treatment plan; (4) Those with intracranial aneurysms, vascular malformations, or brain tumors; (5) Patients with severe brain dysfunction; (6) Those with hemoglobin below 100 g/L, platelet count less than 100 × 109/L, or international normalized ratio (INR) greater than 1.5 (irreversible), with uncorrectable bleeding factors; (7) Those with severe spinal deformities that affect acupuncture at the Governor Vessel; (8) Those with contraindications for MRI examinations, such as implanted metal devices or claustrophobia; (9) Those with severe intracranial anatomical asymmetry or clear lesions found in MRI scan results. If any of the above applies, exclusion is warranted.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer Limb Function Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| National Institutes of Health Stroke Scale;Modified Barthel Index;Serum Vasoactive intestinal polypeptide;Serum Substance P;Functional Magnetic Resonance Imaging; | — |
Countries
China
Contacts
Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital